Skip to main content
. 2017 Jun 2;96(22):e6989. doi: 10.1097/MD.0000000000006989

Figure 3.

Figure 3

(A) Subgroup analysis of continuous outcomes compared with placebo based on the type of tricyclic antidepressants. (B). Subgroup analysis of continuous outcomes compared with placebo based on the treatment duration. (C). Subgroup analysis of continuous outcomes compared with placebo based on the sample size. (D) Subgroup analysis of continuous outcomes compared with placebo based on the type of measurement.